期刊文献+

核转录因子-κB抑制蛋白激酶小分子干扰RNA增强人胶质瘤细胞替莫唑胺化疗敏感性 被引量:4

Nuclear factor-κB kinases β targeting small interfering RNA enhanced human glioma cells to temozolomide chemotherapy sensitivity
原文传递
导出
摘要 目的 观察核转录因子-κB抑制蛋白激酶(IKKβ)小干扰RNA(siRNA)对耐替莫唑胺(TMZ)的胶质瘤细胞株TR-U251和TR-LN229增殖的影响,探讨IKKβ干扰在耐药细胞TMZ化疗敏感性中的作用.方法 体外分步诱导法建立TMZ耐药细胞株TR-U251和TR-LN229,分别用25、50、100 μmol/L siRNA转染耐药细胞,逆转录-聚合酶链反应(RT-PCR)法鉴定IKKβ mRNA表达量;噻唑蓝(MTT)法测定50 μmol/L IKKβ siRNA干扰前后各组细胞TMZ半数抑制浓度(IC50)值并计算耐药指数;转染50 μmol/L IKKβ siRNA的耐药细胞分别联合或不联合IC20TMZ,MTT法检测细胞的增殖抑制率.结果 25 μmol/L IKKβ siRNA干扰效果最弱,50μmol/L和100 μmol/L效果较强;进行50 μmol/L IKKβ siRNA干扰24 h,TR-U251干扰前后对TMZ耐药指数分别为5.92±0.66和0.45±0.07;TR-LN229干扰前后分别为6.58 ±0.29和0.22±0.10;50 μmol/L IKKβ siRNA单独作用TR-U251和TR-LN229细胞48 h增殖抑制率分别为(17.47±4.11)%、(5.90±2.81)%,120μmol/LTMZ单独作用TR-U251 48 h细胞增殖抑制率为(7.87±3.29)%,60 μmol/L TMZ单独作用TR-LN229 48 h细胞增殖率为(24.67±5.37)%,而IKKβ干扰与TMZ联合作用48 h,TR-U251和TR-LN229细胞增殖抑制率分别为(66.33±9.18)%、(75.30±6.01)%.结论 IKKβ RNA干扰显著降低TR-U251与TR-LN229对TMZ的耐药指数及增殖率,增加TMZ化疗的敏感性. Objective To observe the effects of nuclear factor-κB kinases β(IKKβ) small interfering RNA (siRNA) on the proliferation and apoptosis in temozolomide (TMZ)-resistant glioma cell lines TR-U251 and TR-LN229,and to explore the role of IKKβ siRNA in TMZ chemotherapy sensitivity.Methods TMZ resistant cell lines TR-U251 and TR-LN229 were constructed by stepwise exposure of parental cells to TMZ in vitro.The TMZ resistant cells were transfected by 25,50 and 100 μmol/L siRNA respectively and then reverse transcriptase-polymerase chain reaction (RT-PCR) was used to detect the IKKβ mRNA expression levels.The TMZ resistance index of TR-U251 and TR-LN229 cells was analyzed by methyl thiazol tetrazolium (MTT) with or without transfection of 50 μmol/L siRNA for 24 h.The resistant cells were divided into 50 μmol/L siRNA transfection for 48 h group and non-transfection group,respectively,combined with or without IC20 TMZ.The cell proliferation inhibition rate was analyzed by MTT.Results Both 50 and 100 μmol/L siRNA inhibited more significantly the IKKβ mRNA expression than 25 μmol/L siRNA.The TMZ resistance index of TR-U251 and TR-LN229 cells was respectively 5.92 ±0.66 and 6.58 ±0.29,however,after transfection by 50 μmoL/L siRNA for 24 h,the TMZ resistance index of TR-U251 and TR-LN229 cells was respectively 0.45 ± 0.07 and 0.22 ± 0.10.The proliferation inhibition rate for TR-U251 and TR-LN229 cells was respectively (17.47 ±4.11) %,(5.90 ±2.81) % in 50 μmol/L IKKβ siRNA alone,and that was (7.87 ± 3.29)% in 120 μmol/L TMZ alone for TR-U251 group,(24.67 ± 5.37) % in 60 μmol/L TMZ alone for TR-LN229 group,however,when combined with IKKβ siRNA for 48 h,TR-U251 and TR-LN229 cell proliferation inhibition rate was respectively (66.33 ± 9.18) %,(75.30 ± 6.01) %.Conclusion The IKKβ RNA interference significantly decreased the TMZ resistance index and the proliferation,thus increased the TMZ chemotherapy sensitivity in TR-U251 and TR-LN229 cells.
出处 《中华实验外科杂志》 CAS CSCD 北大核心 2013年第11期2330-2332,共3页 Chinese Journal of Experimental Surgery
关键词 胶质瘤 化疗耐药 替莫唑胺 核转录因子-κB抑制蛋白激酶 Keywords:Glioma Chemotherapy-resistance Temozolomide Nuclear factor-κB kinases β
  • 相关文献

参考文献7

二级参考文献17

  • 1陈春美,杨卫忠,王春华,杨贤义,罗望池,任保刚,易海波,石松生,倪天.人脑胶质瘤U251耐药细胞株的建立及耐药相关蛋白的筛选[J].中华实验外科杂志,2006,23(3):375-375. 被引量:4
  • 2綦斌,罗毅男,田宇.全反式维甲酸对脑胶质瘤细胞Cyclin E、Caspase-3表达的影响[J].中华实验外科杂志,2006,23(6):721-723. 被引量:7
  • 3Sathornsumetee S Rich JN.New treatment strategies for malignant gliomas[J].中国神经肿瘤杂志,2006,4(2):92-92. 被引量:5
  • 4Reithmeier T, Graf E, Piroth T, et al. BC- NU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors. BMC Cancer,2010,10:30-37. 被引量:1
  • 5Karmakar S, Banik NL, Ray SK. Combina- tion of All-trans retinoic acid and paclitax- el-induced differentiation and apoptosis in human glioblastoma U87MG xenografts in nude mice. Cancer, 2008,112 : 596 -607. 被引量:1
  • 6Yip-Schneider MT, Nakshatri H, Sweeney C J, et al. Pathenolide and sulindac cooper- ate to mediate growth suppression and in- hibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells. Mol Cancer Ther, 2005,4 : 587 -594. 被引量:1
  • 7Stupp R, Hegi ME, van den Bent M J, et al. Changing paradigms:an update on the multidisciplinary management of malignant glioma. J Oncologist ,2006,11 : 165-180. 被引量:1
  • 8Higgins CF. Multiple molecular mechanisms for multidmg resistance transporters. Nature, 2007,446:749-757. 被引量:1
  • 9Snow K,Judd W. Characterisation of adriamyin-and amsaerine-resist- ant human leukaemic T cell lines. Br J Cancer, 1991,63:17-28. 被引量:1
  • 10Wesarg E,Hoffarth S,Wiewrodt R, et al. Targeting BCL-2 family pro- teins to overcome drug resistance in non-small cell lung cancer. Int J Cancer, 2007,121 : 2387-2394. 被引量:1

共引文献9

同被引文献35

  • 1于耀宇,马廉亭,秦尚振,李安民,徐国政,龚杰,张新元,姚国杰.脑胶质细胞瘤术后间质化疗联合同步放疗的临床研究[J].中国临床神经外科杂志,2005,10(5):342-344. 被引量:9
  • 2王丽娜,刘成海,陈园,陶艳艳,周滔,陈高峰.一种改良的二甲基亚硝胺肝纤维化模型诱导方法及其病理特点[J].中国实验动物学报,2007,15(2):90-94. 被引量:17
  • 3Bartlett NW,Slater L,Glanville N,et al. Defining critical roles for NF-κB p65 and type I interferon in innate immunity to rhinovirus[ J]. EMBO Mol Med,2012,4(12) :1244-1260. 被引量:1
  • 4Kiessling MK, Linke B, Brechmann M, et al. Inhibition of NF-κB in- duces a switch from CD95L-dependent to CD95L-independent and JNK-mediated apoptosis in T cells [ J ]. FEBS Lett,2010,584 (22) : 4679-4688. 被引量:1
  • 5Sunami Y, Leithauser F, Gul S, et al. Hepatic activation of IKK/NFκB signaling induces liver fibrosis via maerophage-mediated chronic inflammation [ J ]. Hepatology ,2012,56 ( 3 ) : 1117-1128. 被引量:1
  • 6Gonz61ez-Ramos R, Defr-re S, Devoto L. Nuclear factor-kappaB : a main regulator of inflammation and cell survival in endometriosis pathophysiology[J]. Fertil Steri1,2012,98 ( 3 ) :520-528. 被引量:1
  • 7Stollenwerk MM, Lasson A, Andersson R. Active site-inactivated factor VIIa inhibits nuclear factor kappa B activation in intestinal ischemia and reperfusion [ J ]. J Surg Res,2012,178 (2) :692-699. 被引量:1
  • 8Williams V, Brichler S, Khan E, et al. Large hepatitis delta antigen activates STAT-3 and NF-κB via oxidative stress[ J]. J Viral Hepat, 2012,19(10) :744-753. 被引量:1
  • 9Komives EA. Consequences of fuzziness in the NFKB/IκBα interaction[ J]. Adv Exp Med Biol,2012,725 (3) :74-85. 被引量:1
  • 10雷三喜,周厚俊,肖宗宇,王宗保,余化霖,马以骝.秋水仙碱对胶质瘤细胞抑制作用的体外实验研究[J].昆明医学院学报,2008,29(5):85-88. 被引量:3

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部